🇺🇸 FDA
Drug

buprenorphine

Brand: BUPRENORPHINE

approved

Quick answer

buprenorphine (BUPRENORPHINE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

Key facts

INN
buprenorphine
Brand
BUPRENORPHINE
Route
SUBCUTANEOUS
Formulation
FILM, EXTENDED RELEASE
Originator
Amneal Pharmaceuticals

Related patents

patent

US 11839611

Buprenorphine dosing regimens

Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11000520

Buprenorphine dosing regimens

Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10592168

Injectable flowable composition comprising buprenorphine

Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10558394

Injectable flowable composition comprising buprenorphine

Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10517864

Sustained-release buprenorphine solutions

Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10198218

Injectable flowable composition comprising buprenorphine

Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10172849

Compositions comprising buprenorphine

Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10022367

Sustained-release buprenorphine solutions

Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is buprenorphine?

buprenorphine (BUPRENORPHINE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for buprenorphine?

BUPRENORPHINE is a marketed brand name for buprenorphine. Check FDA Drugs@FDA for the current US label holder.